Study Stopped
Although patients were screened, only two met the eligibility criteria within the available timeframe. None of the two eligible patients agreed to participate in the study, as a result, no patients were enrolled in the study.
Exercise for Improving Radiotherapy Efficacy in Rectal Cancer
A Single Arm Feasibility Study of Exercise for Improving Short-course Radiotherapy Efficacy in People Diagnosed With Locally Advanced Rectal Cancer
1 other identifier
interventional
N/A
1 country
1
Brief Summary
This is a single arm feasibility study of exercise for improving short- course neoadjuvant radiotherapy efficacy in people diagnosed with locally advanced rectal cancer. The study aims to recruit up to 30 patients from the Queen's Centre for Oncology and Haematology of Castle Hill Hospital, Cottingham, diagnosed with locally advanced rectal cancer. Consenting patient's will be provided with a 7 weeks course of structured aerobic exercises and resistance training in the periods before, during and after their radiotherapy treatment. The patients will be followed up for 6 months post short course neoadjuvant radiotherapy, with a total of 3 assessment periods.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Sep 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 2, 2024
CompletedFirst Posted
Study publicly available on registry
March 5, 2024
CompletedStudy Start
First participant enrolled
September 17, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 17, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 17, 2026
CompletedMarch 6, 2026
March 1, 2026
1.4 years
February 2, 2024
March 4, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Recruitment rate
The number of recruited participants/ total number of patients approached in percentage.
This will be monitored in the total 6months of participants engagement if the study
Attendance rate
The number of supervised exercise sessions attended/ total number of available supervised exercise sessions in percentage.
This will be monitored in the total 6months of participants engagement if the study
withdrawal rate
The number of participants who drop out of study/ total number of recruited participants in percentage.
This will be monitored in the total 6months of participants engagement if the study
Secondary Outcomes (4)
Serum Carcinoembryonic antigen levels
up to 4 weeks before neoadjuvant radiotherapy (NART), immediately following radiotherapy and 6-months following NART
Quality of life assessment
up to 4 weeks before NART, up to 1 week post NART and 6-months following NART
EORTC-QLQ-CR29 version 2.1 questionnaire for Quality of life assessment
up to 4 weeks before NART, up to 1 week post NART and 6-months following NART
Physical activity levels
up to 4 weeks before NART, up to 1 week post NART and 6-months following NART
Study Arms (1)
single arm
EXPERIMENTALThis study involves a single arm only. Therefore all consenting participants will receive the exercise intervention detailed in the protocol. The exercise interventions include an 7-week aerobic and resistance training delivered 2-weeks before chemoradiotherapy commences , in the 1-week of radiotherapy and 4 weeks following chemoradiotherapy. 2-days Aerobic exercise will be delivered on vigorous intensity on a cycle ergometer. This will be under the supervision of a trained physiotherapist. 2-days Resistance training will be home based with guidance of an exercise sheet.
Interventions
7-weeks course of aerobic and resistance exercise, delivered 2 weeks before neoadjuvant radiotherapy (NART), 1 week of NART and 4 weeks post NART.
Eligibility Criteria
You may qualify if:
- years or older
- Have been diagnosed with locally advanced rectal cancer using MRI (Magnetic Resonance Imaging) and histological finding,
- Have been offered short-course neoadjuvant radiotherapy in the Queens Centre, Castle Hill Hospital
- Willing and able to comply with all study requirements
- Able and willing to voluntarily give informed consent to take part.
You may not qualify if:
- Inability to understand basic written and spoken English, as research materials will all be written in English.
- Any movement deficiencies limiting ability to engage in exercise.
- Impaired cognition and/or capacity limiting ability to provide informed consent.
- Cardiovascular and/or cardiopulmonary conditions that will impede ability to safely perform exercise.
- Severe psychiatric disorders.
- With any other health condition which oncologists and research team agrees will impede ability to safely perform exercises.
- Presence of metastatic cancer.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Hulllead
- Hull University Teaching Hospitals NHS Trustcollaborator
Study Sites (1)
Castle Hill Hospital
Hull, East Yorkshire, HU16 5JQ, United Kingdom
Related Publications (5)
Moug SJ, Mutrie N, Barry SJE, Mackay G, Steele RJC, Boachie C, Buchan C, Anderson AS. Prehabilitation is feasible in patients with rectal cancer undergoing neoadjuvant chemoradiotherapy and may minimize physical deterioration: results from the REx trial. Colorectal Dis. 2019 May;21(5):548-562. doi: 10.1111/codi.14560. Epub 2019 Feb 16.
PMID: 30657249RESULTLoughney L, West MA, Moyses H, Bates A, Kemp GJ, Hawkins L, Varkonyi-Sepp J, Burke S, Barben CP, Calverley PM, Cox T, Palmer DH, Mythen MG, Grocott MPW, Jack S; Fit4Surgery group. The effects of neoadjuvant chemoradiotherapy and an in-hospital exercise training programme on physical fitness and quality of life in locally advanced rectal cancer patients: a randomised controlled trial (The EMPOWER Trial). Perioper Med (Lond). 2021 Jun 22;10(1):23. doi: 10.1186/s13741-021-00190-8.
PMID: 34154675RESULTAlejo LB, Pagola-Aldazabal I, Fiuza-Luces C, Huerga D, de Torres MV, Verdugo AS, Ortega Solano MJ, Felipe JL, Lucia A, Ruiz-Casado A. Exercise prehabilitation program for patients under neoadjuvant treatment for rectal cancer: A pilot study. J Cancer Res Ther. 2019 Jan-Mar;15(1):20-25. doi: 10.4103/jcrt.JCRT_30_17.
PMID: 30880749RESULTDwyer CP, Moses A, Rogers FM, Casey D, Joyce R, Hynes SM. A qualitative investigation of reasoning behind decisions to decline participation in a research intervention: A study-within-a-trial. J Health Psychol. 2023 Mar;28(4):374-387. doi: 10.1177/13591053211037736. Epub 2021 Aug 6.
PMID: 34355599RESULTChen T, Zhu H, Su Q. Effectiveness and Safety of Four Aerobic Exercise Intensity Prescription Techniques in Rehabilitation Training for Patients with Coronary Heart Disease. Cardiol Res Pract. 2022 Jul 15;2022:1647809. doi: 10.1155/2022/1647809. eCollection 2022.
PMID: 35874554RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
John Saxton
University of Hull
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 2, 2024
First Posted
March 5, 2024
Study Start
September 17, 2024
Primary Completion
February 17, 2026
Study Completion
February 17, 2026
Last Updated
March 6, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share
No Individual participant data will be made available to other researchers. Anonymised data from the study group will be available for auditing.